Clinical Trials Browser

Phase 2 × OTHER × Endometrial Hyperplasia × Clear all

NCT07107334 2026-04-09

A Study to Estimate Early Clinical Efficacy Signals of GLP-1 Agonist Administration in Conjunction With Levonorgestrel Intrauterine Device in Obese Patients With Endometrioid Intraepithelial Neoplasia

Phase 2 Recruiting

Endometrial Hyperplasia, Endometrial Neoplasms

NCT07377734 2026-03-30

2026ColECFerSp

Phase 2 Recruiting

Endometrial Hyperplasia, Endometrial Neoplasms

NCT07436793 2026-02-27

Progestins for the Treatment of Endometrial Cancer or Precancers of the Uterus Before Surgery, The Pro-Window Trial

Phase 2 Not yet recruiting

Endometrial Hyperplasia

NCT02397083 2026-02-13

LEVER

Phase 2 Active not recruiting

Endometrial Hyperplasia

NCT04576104 2026-01-21

Megestrol Acetate Compared With Megestrol Acetate and Metformin to Prevent Endometrial Cancer

Phase 2 Active not recruiting

Endometrial Hyperplasia, Endometrial Neoplasms

NCT05903131 2026-01-20

Uterine Preservation Via Lifestyle Transformation

Phase 2 Recruiting

GynecologicOther

Endometrial Hyperplasia, Obesity, Endometrial Neoplasms

NCT07078838 2026-01-16

Tirzepatide in Women With Obesity and Endometrial Intra-epithelial Neoplasia or Grade 1 Endometrial Cancer

Phase 2 Not yet recruiting

GynecologicOther

Endometrial Hyperplasia, Hyperplasia, Obesity, Endometrial Neoplasms

NCT03671811 2026-01-06

Megestrol Acetate With or Without Pterostilbene in Treating Patients With Endometrial Cancer Undergoing Hysterectomy

Phase 2 Active not recruiting

44 enrolled 12 charts

Endometrial Hyperplasia, Endometrial Neoplasms

NCT00788671 2025-08-15

Levonorgestrel-Releasing Intrauterine System in Treating Patients With Complex Atypical Hyperplasia or Grade I Endometrial Cancer

Phase 2 Active not recruiting

69 enrolled 10 charts

Endometrial Hyperplasia

NCT06102863 2025-04-29

Progesterone Therapeutic Regimen Plus Statins in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia

Phase 2 Recruiting

Endometrial Hyperplasia, Endometrial Neoplasms

NCT05675787 2024-07-11

Medroxyprogesterone Acetate Plus Atorvastatin in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia

Phase 2 Recruiting

Endometrial Hyperplasia, Endometrial Neoplasms

NCT00483327 2018-04-04

Management of Atypical Endometrial Hyperplasia and Endometrial Carcinoma Using Megestrol Acetate

Phase 2 Completed

31 enrolled 9 charts

Endometrial Hyperplasia, Endometrial Neoplasms

NCT01943058 2014-09-10

Megestrol Acetate or Levonorgestrel-Releasing Intrauterine System in Treating Patients With Atypical Endometrial Hyperplasia or Endometrial Cancer

Phase 2 Withdrawn

Endometrial Hyperplasia, Endometrial Neoplasms

NCT01234818 2012-11-12

KGOG2006

Phase 2 Unknown

Endometrial Hyperplasia

NCT00919919 2009-06-12

Efficacy and Tolerability Study of Progesterone Vaginal Tablets (Endometrin®) in Menopausal Women Treated by Estrogen

Phase 2 Unknown

Endometrial Hyperplasia, Endometrial Neoplasms